Ortner NJ - Search Results

1

Ca_v 1.3-selective inhibitors of voltage-gated L-type Ca²⁺ channels: Fact or (still) fiction?

Filippini L, Ortner NJ, Kaserer T, Striessnig J. Filippini L, et al. Among authors: ortner nj. Br J Pharmacol. 2023 May;180(10):1289-1303. doi: 10.1111/bph.16060. Epub 2023 Mar 14. Br J Pharmacol. 2023. PMID: 36788128 Free PMC article. Review.

2

[Equal Opportunities for Care in Obstetrics - A Quantitative Survey of Accessibility in Obstetric Departments in Austria].

Schildberger B, Ortner N, Zenzmaier C, König-Bachmann M. Schildberger B, et al. Z Geburtshilfe Neonatol. 2016 Apr;220(2):74-80. doi: 10.1055/s-0035-1555763. Epub 2016 Apr 25. Z Geburtshilfe Neonatol. 2016. PMID: 27111594 German.

3

C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels.

Lieb A, Ortner N, Striessnig J. Lieb A, et al. Biophys J. 2014 Apr 1;106(7):1467-75. doi: 10.1016/j.bpj.2014.02.017. Biophys J. 2014. PMID: 24703308 Free PMC article.

4

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators.

Ortner NJ, Bock G, Vandael DH, Mauersberger R, Draheim HJ, Gust R, Carbone E, Tuluc P, Striessnig J. Ortner NJ, et al. Nat Commun. 2014 Jun 19;5:3897. doi: 10.1038/ncomms4897. Nat Commun. 2014. PMID: 24941892 Free PMC article.

5

Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?

Striessnig J, Ortner NJ, Pinggera A. Striessnig J, et al. Among authors: ortner nj. Curr Mol Pharmacol. 2015;8(2):110-22. doi: 10.2174/1874467208666150507105845. Curr Mol Pharmacol. 2015. PMID: 25966690 Free PMC article. Review.

6

L-type calcium channels as drug targets in CNS disorders.

Ortner NJ, Striessnig J. Ortner NJ, et al. Channels (Austin). 2016;10(1):7-13. doi: 10.1080/19336950.2015.1048936. Epub 2015 Jun 3. Channels (Austin). 2016. PMID: 26039257 Free PMC article. Review.

7

A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated CaV1.2 Calcium Channel Function.

Kaur G, Pinggera A, Ortner NJ, Lieb A, Sinnegger-Brauns MJ, Yarov-Yarovoy V, Obermair GJ, Flucher BE, Striessnig J. Kaur G, et al. Among authors: ortner nj. J Biol Chem. 2015 Aug 21;290(34):21086-21100. doi: 10.1074/jbc.M115.645671. Epub 2015 Jun 22. J Biol Chem. 2015. PMID: 26100638 Free PMC article.

8

Lower Affinity of Isradipine for L-Type Ca²⁺ Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease.

Ortner NJ, Bock G, Dougalis A, Kharitonova M, Duda J, Hess S, Tuluc P, Pomberger T, Stefanova N, Pitterl F, Ciossek T, Oberacher H, Draheim HJ, Kloppenburg P, Liss B, Striessnig J. Ortner NJ, et al. J Neurosci. 2017 Jul 12;37(28):6761-6777. doi: 10.1523/JNEUROSCI.2946-16.2017. Epub 2017 Jun 7. J Neurosci. 2017. PMID: 28592699 Free PMC article.

9

RBP2 stabilizes slow Cav1.3 Ca²⁺ channel inactivation properties of cochlear inner hair cells.

Ortner NJ, Pinggera A, Hofer NT, Siller A, Brandt N, Raffeiner A, Vilusic K, Lang I, Blum K, Obermair GJ, Stefan E, Engel J, Striessnig J. Ortner NJ, et al. Pflugers Arch. 2020 Jan;472(1):3-25. doi: 10.1007/s00424-019-02338-4. Epub 2019 Dec 17. Pflugers Arch. 2020. PMID: 31848688 Free PMC article.

10

Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder.

Hofer NT, Tuluc P, Ortner NJ, Nikonishyna YV, Fernándes-Quintero ML, Liedl KR, Flucher BE, Cox H, Striessnig J. Hofer NT, et al. Among authors: ortner nj. Mol Autism. 2020 Jan 8;11(1):4. doi: 10.1186/s13229-019-0310-4. eCollection 2020. Mol Autism. 2020. PMID: 31921405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page